Stocks
Avanos Medical (AVNS) R&D/CAPEX US GAAP (year values) |
|||||||||
| 2020 | 2021 | 2022 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| R&D/CAPEX, % | 172.8% | 153.8% | 158.5% | 158.5% | 152.8% | 149.2% | |||
| Changes by years, y/y, % | +98pp | -19pp | +5pp | 0pp | -6pp | +12.4% | |||
Avanos Medical. R&D/CAPEX, %
Avanos Medical. R&D/CAPEX, changes, pp
Avanos Medical (AVNS) R&D/CAPEX US GAAP (quarter values) |
||||||||
| 2023Q1 | 2023Q2 | 2023Q3 | 2023Q4 | 2024Q1 | LTM ? | |||
| R&D/CAPEX, % | 197.5% | 170.0% | 156.4% | 115.3% | 170.7% | 149.2% | ||
| Changes by years, y/y, % | +42pp | -25pp | +19pp | -38pp | -27pp | |||
| Changes by quarters, q/q, % | +44pp | -28pp | -14pp | -41pp | +55pp | |||
